This oral presentation aims to discuss the results of my research on the incidence and attack rates of first-ever ischaemic stroke in patients with atrial fibrillation. Stroke is one of the most prevalent causes of death and debilitating neurological conditions. Globally, the absolute number of stroke patients is rising, with high-income countries showing a higher stroke prevalence than low- and middle-income countries. Atrial fibrillation is one of the most common cardiac arrhythmia and a well-known risk factor for ischaemic stroke. It is associated with a five-fold increase in ischaemic stroke risk, more likely to be severe or fatal. In New Zealand, there have been no previous population-based incidence studies of ischaemic stroke in patients with atrial fibrillation. The design of this study allowed, for the first time, an accurate estimation of the frequency of ischaemic stroke in patients with atrial fibrillation, identifying knowledge gaps specific to New Zealand and providing essential information for health policy development. In this study, the pre-stroke prevalence of atrial fibrillation appeared to be very high and was strongly associated with established cardiovascular risk factors. During the study period, the crude incidence rate of first-ever ischaemic stroke in atrial fibrillation patients in the Auckland population was higher than that reported in other population-based studies. The aging of the population could partlyexplain the increasing incidence of ischaemic stroke associated with atrial fibrillation in developed countries, including New Zealand. The atrial fibrillation detection at the time of stroke onset was significantly improved by using historical hospital archives. Moreover, a longer post-stroke duration of electrocardiographic monitoring was associated with higher newly diagnosed atrial fibrillation detection, demonstrating that prolonged monitoring should be considered for all stroke survivors.
Aim Public health officials recommended the use of face masks by the population to combat the transmission of COVID-19. Studies on self-reported behaviour are a poor substitute for assessing adherence to government recommendations. This study aimed to determine the percentage of pedestrians wearing masks in the Central Business District (CBD) and a suburb of Auckland, New Zealand (NZ). Methods This direct observational study of pedestrians crossing two busy intersections occurred between 22 August 2020 and 7 March 2022. Data collection occurred at three separate times during the day, in the morning (from 8 to 9 am), noon (from 12 to 1 pm) and afternoon (from 4 to 5 pm) for precisely one hour each time. Results Over 12 days of COVID alert level restrictions, we observed 30,855 pedestrians. Overall, 57.9% of pedestrians wore a mask outdoors. Masks-wearing was significantly higher in the CBD (64.0%) than in the suburb (38.7%), p < 0.001. Masks use was lower in the morning (51.1%) than at noon (56.1%) or afternoon (62.7%), p < 0.001, both in the CBD and the suburb. Conclusion This was the first observational study in NZ examining the public’s mask use during the COVID-19 pandemic. From our observations, there may be opportunities for improvement in public face mask use rates to decrease the spread of COVID-19 in the population. In addition, our findings can inform national and international public health agencies about face mask uptake in public.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.